Skip to main content
. 2022 Jun 23;13:908528. doi: 10.3389/fimmu.2022.908528

Table 1.

Laboratory test results before and after treatment.

Items Measured value Reference range
Before treatment After treatment
RBC (×1012/L) 3.33 4.07 3.5-5
Hb (g/L) 129 125 110-150
MCV (fL) 110.2 92.60 82-95
MCH (pg) 38.7 30.70 27-31
MCHC (g/L) 351 332 320-360
RBC volume distribution width (fl) 54.0 39.80 39.0-46.0
Platelet (×109/L) 388 231 100-350
Thrombocytocrit (%) 0.31 0.23 0.10-0.28
WBC (×109/L) 5.83 4.14 4-10
Vitamin B12 (pg/ml) 74.00 Medication 180-914
Folic acid (ng/ml) >23.90 Medication 3.1-19.9
ESR (mm/h) 37 17 0-20
Homocysteine (μmol/L) 124.1 11.0 0-20
GGT (U/L) 55 24 7-45
A/G 1.49 1.72 1.5-2.5
Intrinsic factor antibody (Au/ml) Positive (8.92) Negative
Parietal cell antibody +1:80 +1:80 Negative
ANA +1:320
(centromere type)
+1:160
(centromere type)
Negative
Anti CENP B antibody +++ ++ Negative
Anti SSA60 + Negative Negative
CCP Negative Negative
RF Negative Negative Negative
MTHFR Mutant type (TT) Negative
CYFRA21-1 (ng/ml) 3.47 3.84 0.1-3.3
CA72-4 (U/ml) 127.00 18.10 0-6.9
Alpha-fetoprotein (ng/ml) 13.70 (0.01-7) 10.08 (0.00-15) In parentheses
C13 breath test Negative Negative Negative
γ-globulin (%) 14.6 NA 9.1-24.0
β2-microglobulin (%) 6.3 NA 1.8-6.2
α1-globulin (%) 5.2 NA 2.2-4.8

RBC, red-cell count; Hb, hemoglobin; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpusular hemoglobin concerntration; WBC, white blood cell; ESR, erythrocyte sedimentation rate; GGT, gamma-glutamyl transferase; ANA, anti-nuclear antibody; CCP, anti-cyclic citrullinated peptide antibody; RF, rheumatoid factors; MTHFR, Methylene tetrahydrofolate reductase; CA72-4, Cancer antigen CA72-4; NA, not available.

+ refers to a lighter degree, +++ refers to a heavier degree, and ++ refers to a degree between the two.